FMGE · blueprint and recall
FMGE Insulin and oral antidiabetics
Candidates recalled insulin and oral antidiabetics from 10 of the 19 FMGE sessions in this collection, including 8 of the 11 well-covered ones. It first appears in FMGE Jun 2009 and last in FMGE Jul 2025. 8 of its 10 recalled concepts came as one-liners.
- Concepts in recalled topics
- 10
- unofficial
- Sessions seen in
- 10
- Well-covered sessions
- 8
- with this topic recorded
- Image-linked concepts
- 0
Recurrence in this collection
Each recalled session counts once for this topic, even if it contains several related concepts.
Seen in 10 of the 19 sessions with recall; 8 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.
First and last seen refer to this recall collection only. Thin coverage limits what absence can tell you. Read the method.
Question styles and image links
Question styles in the recall
- one-liner
- 8 concepts · 80.0%
- vignette
- 2 concepts · 20.0%
Within this topic
Finer labels from the unofficial recall, grouped under Lumi's outline topic.
Subtopics represented
- Diabetes insipidus
- Incretin mimetics
- Antidiabetic adverse effects
- Insulin and oral antidiabetics
- Antidiabetics in cardio-renal disease
- Oral antidiabetics
Image types recorded
No concepts recorded in this category.
Image-type percentages use all 10 concepts in this topic as the denominator. The labels describe images in recall; no images are reproduced.
Related topics in this chapter
Endocrine
Thyroid drugs
Seen in 4 of the 19 sessions with recall; 3 of the 11 well-covered sessions.
First seen: FMGE Jun 2011. Last seen: FMGE Jun 2022.
Styles: one-liner (3) · vignette (1).
Endocrine
Sex hormones and contraceptives
Seen in 4 of the 19 sessions with recall; 3 of the 11 well-covered sessions.
First seen: FMGE Dec 2010. Last seen: FMGE Jul 2025.
Styles: one-liner (2).
Endocrine
Corticosteroids
Seen in 4 of the 19 sessions with recall; 2 of the 11 well-covered sessions.
First seen: FMGE Jun 2009. Last seen: FMGE Jun 2019.
Styles: one-liner (3).
Endocrine
Drugs for osteoporosis
Seen in 1 of the 19 sessions with recall; 1 of the 11 well-covered sessions.
First seen: FMGE Jan 2025. Last seen: FMGE Jan 2025.
Styles: one-liner (1).